Asia Pacific Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), Antisense RNA and Others), Application (Genetic Engineering, Cell Line Engineering and Others) End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes), and Country
Publication Month: Apr 2019
Report Code: TIPRE00003915 No. of Pages: 145 Category: Biotechnology Status: Published
The Asia Pacific genome editing market is expected to reach US$ 2349.9 Mn in 2025 from US$ 673.3 Mn in 2017. The market is estimated to grow with a CAGR of 17.7% from 2018-2025.
The growth of the market is driven by the factors such as, increase in funding for the genome editing and medical genetics in developing countries. However, the market is likely to get impacted due to the perception of the people for genetic alteration and tighten rules on gene editing.
The market for the genome editing is expected to grow in the coming near future due to the growth factor that is driving the market majorly is increase in the funding. The different government in the different regions are increasing their funds and grants for the development of the genome editing research. Across the world funding are being provided by the every nation, for instance, the National Institutes of Health (NIH) has kept approximately US$ 45.5 million aside for the next four fiscal years for Somatic Cell Genome Editing program. Moreover, in the Asia Pacific region, the countries are also investing more for the development of the genome editing technology since two three years back. For instance, in April 2016, Japan invested approximately US$76million for the five years for the creation of Japanese owned genome editing technologies. The rise in the funding for the genome editing is likely to drive the market for the genome editing in the forecast period.
Additionally, the increasing advances in genetic and genomic technology have changed the healthcare services rapidly in low and middle income countries (LMICs) in the Asia-Pacific region. Although, genetic services were initially focused on population-based disease prevention strategies and then evolved into clinic-based and therapeutics-oriented services. Many health-care systems in the region were unprepared for the needs of a clinical genetic service and have struggled to cope with both, communicable and non-communicable diseases. The combination of demands from a large emerging middle class population, the lack of regulatory oversight and capacity-building in medical genetics expertise help to upsurge the demand for the genetic services.
China is expected to lead the market in the Asia Pacific region owing to increase in the investments by the governments of the respective countries in the region. The rising development and research for the genome editing along with the clinical trials are expected to drive the genome editing market in the forecast period. In addition, the initiatives to support by the government of India for the startups in biotechnology sectors are likely to foster the growth of the biotechnology market in the country. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.
Exhibit: Rest of Asia Pacific Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)
ASIA PACIFIC GENOME EDITING – MARKET SEGMENTATION
By Technology
- TALENS
- CRISPR
- Zinc Finger Nucleases (ZFNs)
- Others
By Application
- Genetic Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Cell Line Engineering
- Others
By End User
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Government Research Institutes
By Geography
• Asia Pacific
- China
- Japan
- India
Company Profiles
- Transposagen Biopharmaceuticals, Inc.
- Integrated DNA Technologies, Inc.
- Thermo Fisher Scientific Inc.
- GenScript
- Lonza
- Horizon Discovery Group plc
- Sangamo Therapeutics, Inc.
- New England Biolabs
- Editas Medicine
- Merck KGaA
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Asia Pacific GENOME EDITING TESTING Market – Key takeaways
PART 3. Asia Pacific genome editing market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Asia Pacific Genome Editing Market – By Technology
3.2.2 Asia Pacific Genome Editing Market – By Application
3.2.3 Asia Pacific Genome Editing Market – By End User
3.2.4 Asia Pacific Genome Editing Market – By Country
3.3 PEST Analysis
PART 4. Asia Pacific genome editing market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increase in Funding For The Genome Editing
4.1.2 Medical Genetics in Developing Countries
4.2 Key Market Restraints
4.2.1 Perception of the People For Genetic Alteration
4.2.2 Tighten Rules On Gene Editing
4.3 Key Market Opportunities
4.3.1 Gene Editing in Research Activities
4.4 future Trends
4.4.1 Rising Demand for CRISPR Cas9 Technology
4.5 Impact analysis
PART 5. Genome Editing market – Asia Pacific Analysis
5.1 Asia Pacific GENOME EDITING market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
5.4 expert opinions
PART 6. Asia Pacific GENOME EDITING market Analysis – By Technology
6.1 Overview
6.2 ASIA PACIFIC GENOME EDITING MARKET, BY technology, 2017 & 2025 (%)
6.3 Asia Pacific GENOME EDITING market Revenue And Forecasts to 2025, By Technology (US$ Mn)
6.4 transcription activator-like effector nucleases (TALENS) Market
6.4.1 Overview
6.4.2 Asia Pacific Transcription Activator-Like Effector Nucleases (TALENS) Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 clustered regularly interspaced short palindromic repeats (CRISPR) Market
6.5.1 Overview
6.5.2 Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 zinc finger nucleases (ZFNs) Market
6.6.1 Overview
6.6.2 Asia Pacific Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 Antisense RNA Market
6.7.1 Overview
6.7.2 Asia Pacific Antisense RNA Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 Others Market
6.8.1 Overview
6.8.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. Asia Pacific genome editing market Analysis – By Application
7.1 Overview
7.2 ASIA PACIFIC GENOME EDITING MARKET, BY Application, 2017 & 2025 (%)
7.3 Asia Pacific GENOME EDITING market Revenue And Forecasts to 2025, By Application (US$ Mn)
7.4 Genetic Engineering Market
7.4.1 Overview
7.4.2 Asia Pacific Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.4.3 Animal Genetic Engineering Market
7.4.3.1 Overview
7.4.3.2 Asia Pacific Animal Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.4.4 Plant Genetic Engineering Market
7.4.4.1 Overview
7.4.4.2 Asia Pacific Plant Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 cell line engineering Market
7.5.1 Overview
7.5.2 Asia Pacific Cell Line Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 Others Market
7.6.1 Overview
7.6.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. Asia Pacific genome editing market Analysis – By End User
8.1 Overview
8.2 ASIA PACIFIC GENOME EDITING MARKET, BY end user, 2017 & 2025 (%)
8.3 Asia Pacific GENOME EDITING market Revenue And Forecasts to 2025, By end user (US$ Mn)
8.4 Biotechnology & pharmaceutical Companies Market
8.4.1 Overview
8.4.2 Asia Pacific Biotechnology & Pharmaceutical Companies Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 ACADEMIC & GOVERNMENT RESEARCH ORGANIzATIONS Market
8.5.1 Overview
8.5.2 Asia Pacific Academic & Government Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn)
8.6 Contract Research organization Market
8.6.1 Overview
8.6.2 Asia Pacific Contract Research Organization Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9. Asia Pacific genome editing market Revenue and Forecasts to 2025
9.1 Overview
9.2 asia pacific Genome editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.3 Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By Technology(US$ Mn)
9.4 Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.4.1 Asia Pacific Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.5 Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
9.6 Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By Country (%)
9.7 China Genome editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.1 China Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 China Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
9.7.3 China Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.7.3.1 China Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.7.4 China Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
9.8 Japan Genome editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.1 Japan Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Japan Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
9.8.3 Japan Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8.3.1 Japan Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.8.4 Japan Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
9.9 India Genome editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.1 India Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 India Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
9.9.3 India Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9.3.1 India Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)
9.9.4 India Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
PART 10. Genome Editing Market–Key company profiles
10.1 Thermo Fisher Scientific Inc.
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Integrated DNA Technologies, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Merck Kgaa
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT ANALYSIS
10.3.6 KEY DEVELOPMENTS
10.4 Lonza
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 New England Biolabs
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 GenScript
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Transposagen Biopharmaceuticals, inc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product/ Services Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Horizon Discovery Group Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product/ Services Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Sangamo Therapeutics, Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Editas MEdicine
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Service Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
list of tables
TABLE 1. Asia Pacific GENOME EDITING market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 2. Asia Pacific GENOME EDITING market Revenue And Forecasts to 2025, By Application (US$ Mn)
TABLE 3. Asia Pacific GENOME EDITING market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 4. Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 5. Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 6. Asia Pacific genetic engineering Market Revenue And Forecasts to 2025, By type (US$ Mn)
TABLE 7. Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 8. China Genome editing Market Revenue And Forecasts to 2025, By TEchnology (US$ Mn)
TABLE 9. China Genome editing Market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 10. China genetic engineering Market Revenue And Forecasts to 2025, By type (US$ Mn)
TABLE 11. China Genome editing Market Revenue And Forecasts to 2025, By End user (US$ Mn)
TABLE 12. Japan Genome editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 13. Japan Genome editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
TABLE 14. jAPAN genetic engineering Market Revenue And Forecasts to 2025, By type (US$ Mn)
TABLE 15. Japan Genome editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
TABLE 16. India Genome editing Market Revenue And Forecasts to 2025, By TEchnology (US$ Mn)
TABLE 17. India Genome editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)
TABLE 18. India genetic engineering Market Revenue And Forecasts to 2025, By type (US$ Mn)
TABLE 19. India Genome editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)
TABLE 20. Glossary of Terms, GENOME EDITING market
list of figures
FIGURE 1. China genome editing market, Revenue (US$ Mn), By COuntry 2018 & 2025
FIGURE 2. Asia PAcific genome editing Market By Type, Market Share (%), 2017
FIGURE 3. Asia PAcific genome editing Market By services, Market Share (%), 2017
FIGURE 4. Asia Pacific genome editing Market By end user, Market Share (%), 2017
FIGURE 5. genome editing market Segmentation
FIGURE 6. Asia Pacific PEST Analysis
FIGURE 7. genome editing market impact analysis of drivers & Restraints
FIGURE 8. Asia Pacific GENOME EDITING market – Revenue Forecasts and Analysis – 2017- 2025
FIGURE 9. Asia Pacific GENOME EDITING market, By technology, 2017 & 2025 (%)
FIGURE 10. Asia Pacific transcription activator-like effector nucleases (TALENS) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 11. Asia Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 12. Asia Pacific Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 13. Asia Pacific Antisense RNA Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. Asia Pacific GENOME EDITING market By Application, 2017 & 2025 (%)
FIGURE 16. Asia Pacific Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. Asia Pacific Animal Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 18. Asia Pacific Plant Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. Asia Pacific Cell Line Engineering Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 20. Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. Asia Pacific GENOME EDITING market By end user, 2017 & 2025 (%)
FIGURE 22. Asia Pacific Biotechnology & Pharmaceutical Companies Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Asia Pacific academic & government research organizations Market Revenue and Forecasts to 2025
(US$ Mn)
FIGURE 24. Asia Pacific Contract Research Organization Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 25. Asia Pacific genome editing market REVENUE overview, by Country, 2017 (US$ MN)
FIGURE 26. asia pacific Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. Asia Pacific Genome editing Market Revenue And Forecasts to 2025, By Country (%)
FIGURE 28. China genome editing Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 29. Japan Genome editing Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 30. India Genome editing Market Revenue and Forecasts to 2025 (US$ Mn)
The List of Companies
- Transposagen Biopharmaceuticals, Inc.
- Integrated DNA Technologies, Inc.
- Thermo Fisher Scientific Inc.
- GenScript
- Lonza
- Horizon Discovery Group plc
- Sangamo Therapeutics, Inc.
- New England Biolabs
- Editas Medicine
- Merck KGaA